CLMT Calumet, Inc.
CLMT Calumet, Inc.
Basic Materials · Specialty Chemicals
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $20.48 · VWAP $35.04 · +64.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
CLMT Price Structure
Loading timeframes…
Peers
Every watchlist CLMT belongs to, members best 30-day change first — CLMT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported the quarter ending 2026-06-30: revenue $1.45B, diluted EPS -$1.09, net income -$96M (SEC filing). Across the print the stock moved +8.6% (close before → first close after).
full note →Against street estimates
How CLMT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
CLMT research tape
98 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to CLMT.
Refining: the coverage miss, read properly — crack-spread lane, trigger-or-pass